After 20 days of treatment, massive enlargement of tumor volume for both control groups (1300 mm3 and 1100 mm3) were seen in contrast to cyclin-B1-ssiRNA/PEI group (700 mm3). The gene discussed is CCNB1; the disease is neoplasm.